WhatareIPLandaFt?
duoisahome-usedeviceforthepermanentreductionofhairgrowthbasedonIntensePulsedLight(IPL)and
advancedFluorescencetechnology(aFt)thatisfoundinsalonsacrosstheglobe.Itworksbelowtheskin's
surfaceanddoesnotinvolveanycuttingorpulling,reducinghairgrowthwithminimalpain.
duogivesyouthepowertofightunwantedhairgrowthdeliveringlongtermresultsforperfectlysmooth
skin.thecombinationofbothIntensePulseLight(IPL)andadvancedFluorescencetechnology(aFt)ina
singledeviceprovidehighlyflexibletreatmentsthatcanbetailoredperfectlytodifferentpartsofthebody
andtodifferentskintones.ChoosebetweenFreeglideaFtwhichdeliversupto1pulsepersecondforfast
andeasytreatmentsthatarecomfortableevenonsensitiveskinorsingleshotIPLtreatmentswiththebenefit
ofadditionalcontrolwhenusinghigherpower.
Please read all instructions and safety precautions carefully prior to use.
• duoshouldideallybeusedonthelegs,underarms,bikiniline,chest,stomach,armsandonthefacebelow
thecheekbones(notforuseonthefacebymen).
• donotusethedeviceovermucousmembranesi.enoseandears.
• donotusethedeviceoverpiercingoranymetalitemssuchasearringsorjewellery.
• donotusethedeviceontannedskinduring4weeksaftersunexposure(morethan15minutesindirect
sunlightwithoutprotection)asthiscancauseseriousburnsorskininjury.
• avoidmorethan15minutesofdirectsunexposureforatleast2weeksposttreatment.Ifrecentlytreated
skinisexposedtosunlightinthisperiodoftime,makesuretoapplySPF30orhighersunscreens.
• doaspottestonasmallpatchofskinintheintendedtreatmentarea,48hourspriortofirstuseoftheIPL
(seespottestpage5).
• donotusethedeviceonnaturallydarkskin(seeguideonboxandinsidebackcover).
• Keepoutofchildren'sreach.
• thedeviceistobeusedforhairreductionpurposesonly.donotuseitforanyotherpurpose.
• Useduoonlyaccordingtotheinstructionsforuse.
WarnIngSandSaFetyPreCaUtIonS
When shouldn’t Duo be used?
• Pregnantornursingwomenmustavoidtheuseofthedevice.
• donotusethedeviceifyouhaveskincanceroronareasatriskofmalignancy.
• donotusethedeviceifyousufferfromepilepsy.
• donotusethedeviceifyouare/wereunderradiationtherapyorchemotherapywithinthepast3months.
• donotusethedeviceifyouhaveanactiveimplantsuchasapacemaker,insulinpumps,orsimilardevices.
• donotuseondamagedorbrokenskinorifyouhaveahistoryofherpesorPsoriasisoutbreakinthe
treatmentarea.
• donotuseifyousufferfromkelodialscarformation.
• donotuseifyouhavetakentetracyclineantibioticswithinthelasttwoweeks.
• donotuseifyouhavebeentakingmedicationwiththefollowingactiveingredientswithinthelasttwo
weeks:retinoids,accutaneandretin-a.
• donotusethedeviceifyouarephotosensitiveorhaveotherdiseasesrelatedtolightsensitivity.
• donotuseifyousufferfrommetabolicconditions,suchasdiabetes.
• donotuseifyouhavehadaskinpeelorotherskinresurfacingprocedurewithinthelast6–8weeks.
• donotusethedeviceifyouwereexposedtostrongsunlightoranartificialtanningmachineduringthe
past30days.
• donotusethedeviceifyouhavedarkspotssuchaslargefreckles,molesorblistersonthetreatmentarea.
• neVeruseflammableliquidssuchasalcoholoracetonetocleantheskinbeforeusingthedevice.
• donotusethedeviceonthefaceabovethecheekline;aroundtheeyes,eyebrowsoreyelashesasthis
couldcauseseriouseyedamage.
• donotusethedeviceovermucousmembranesasinthenoseandears
3
GB
IB-IPLHH160GB-
0315-01_Layout 1 28/04/2015 09:31 Page 3